-+ 0.00%
-+ 0.00%
-+ 0.00%

Procyrion Announces CEO Transition, Appointing Jason Whiting as New CEO

Barchart·11/17/2026 08:07:00
Listen to the news

Eric S. Fain, MD to retire after more than eight years as CEO, will remain on Board of Directors

HOUSTON, Nov. 17, 2026 /PRNewswire/ -- Procyrion®, Inc., a medical device company developing the novel Aortix® system designed to improve outcomes for patients with cardiac and renal impairment, announced today the appointment of Jason Whiting as President and Chief Executive Officer, succeeding Eric S. Fain, MD, who had served in the role since 2018. Dr. Fain has announced his plans to retire and will remain on Procyrion's Board of Directors to support the company's transition from clinical-stage to commercial-stage.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.